Christine Ocampo
Comptroller/Controller/Auditor at UROVANT SCIENCES LTD.
Christine Ocampo active positions
Companies | Position | Start | End |
---|---|---|---|
UROVANT SCIENCES LTD. | Comptroller/Controller/Auditor | - | - |
Director of Finance/CFO | 01/05/2018 | 28/10/2019 | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Comptroller/Controller/Auditor | 01/10/2017 | - |
Career history of Christine Ocampo
Former positions of Christine Ocampo
Companies | Position | Start | End |
---|---|---|---|
ELEDON PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/05/2017 | 10/07/2017 |
Compliance Officer | 01/05/2017 | 10/07/2017 | |
Director of Finance/CFO | 01/05/2017 | 10/07/2017 | |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Compliance Officer | 22/09/2015 | 01/05/2017 |
Director of Finance/CFO | 22/09/2015 | 01/05/2017 | |
AVANIR PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 17/03/2007 | 01/09/2015 |
Compliance Officer | 17/03/2007 | 01/09/2015 | |
Director of Finance/CFO | 17/03/2007 | 01/09/2015 | |
Corporate Secretary | 17/03/2007 | 01/09/2015 | |
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Comptroller/Controller/Auditor | 01/01/2001 | 05/04/2006 |
Director of Finance/CFO | 01/01/2001 | 05/04/2006 | |
Corporate Secretary | 01/01/2001 | 05/04/2006 | |
Treasurer | 01/01/2001 | 05/04/2006 | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/01/1994 | 01/01/1996 |
Training of Christine Ocampo
Seattle University | Undergraduate Degree |
Statistics
International
United States | 7 |
United Kingdom | 2 |
Bermuda | 2 |
Operational
Comptroller/Controller/Auditor | 6 |
Director of Finance/CFO | 5 |
Compliance Officer | 3 |
Sectoral
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ELEDON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 6 |
---|---|
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
- Stock Market
- Insiders
- Christine Ocampo
- Experience